
Loading, please wait...

Loading, please wait...

Accurate cannabinoid isomer identification is a critical requirement in both forensic toxicology and the emerging field of medicinal cannabis. While the therapeutic use of compounds like cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) grows, the ability to distinguish these structural isomers remains technically demanding. Traditional methods often struggle with thermal instability or identical spectral profiles. This can lead to potential misidentification in legal and clinical settings.
For decades, Gas Chromatography-Electron Ionization-Mass Spectrometry (GC-EI-MS) has been the gold standard for analysis. However, the high temperatures in the GC inlet can cause thermal degradation. Furthermore, it often converts acidic cannabinoids into their neutral forms. In contrast, Liquid Chromatography-Mass Spectrometry (LC-MS) offers a gentler approach. However, even with electrospray ionization (ESI), structural isomers like THC and CBD often yield nearly identical product ion spectra. This similarity significantly reduces the effectiveness of cannabinoid isomer identification using standard tandem mass spectrometry (MS/MS).
Recent research introduces a transformative approach using copper (Cu) salts to induce molecular ion formation. By introducing Cu ions under ESI conditions, analysts can create unique molecular complexes. These copper-cannabinoid adducts exhibit fragmentation patterns similar to electron ionization spectra but without the thermal risks. Additionally, this method allows for the differentiation of thirteen different cannabinoids by producing characteristic ions that act as chemical fingerprints. Therefore, this approach provides a more reliable analytical pathway.
This alternative workflow aligns with the needs of drug analysts and clinicians who require high-confidence data. The generated spectra can be searched against established EI-MS libraries, such as the NIST library. Moreover, the successful application of this technique to real-world cannabis plant extracts demonstrates its robustness. For healthcare providers, these advancements ensure that prescribed cannabinoid products meet strict purity standards. Consequently, patients receive medications that are free from illicit or unintended isomers.
Differentiation is essential because isomers like THC and CBD have vastly different legal statuses and pharmacological effects. Misidentification can lead to incorrect dosing or legal complications for patients and providers.
Copper ions help form unique molecular complexes that fragment into distinct "fingerprint" ions. This allows mass spectrometers to see differences between molecules that otherwise look identical under standard testing conditions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or legal guidance regarding the use of cannabinoids. Refer to the latest local and national guidelines for clinical practice.
References
Couch AN et al. Differentiation of cannabinoid isomers via Cu-mediated molecular ion formation and electrospray ionization-tandem mass spectrometry. J Forensic Sci. 2026 Mar 08. doi: 10.1111/1556-4029.70290. PMID: 41796083.
Couch AN, Zall CM, Davidson JT. Differentiation of CBD and Δ9-THC isomers using copper-ion complexation and electrospray ionization-tandem mass spectrometry. Anal Chim Acta. 2026 Jan 22;1384:344953. doi: 10.1016/j.aca.2025.344953.
Pichini S, et al. Analysis of Cannabinoids in Biological Specimens: An Update. Toxics. 2020;8(1):7. doi: 10.3390/toxics8010007.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a new Cu-mediated ESI-MS/MS method to differentiate cannabinoid isomers, offering a highly accurate alternative to traditional GC...
6 months ago

A recent clinical report details an atypical presentation of bilateral proptosis as the primary manifestation of aggressive multiple myeloma. Explore the diagnostic pathway, imaging findings, and critical multidisciplinary management strategies essential for handling extramedullary plasma cell dyscrasias.
Today

Prenatal evaluation of fetal growth restriction requires an integrated diagnostic approach. While chromosomal microarray remains fundamental, exome sequencing offers significant diagnostic yield in isolated and syndromic cases, especially when ultrasound shows skeletal anomalies or normal placental function.
Today

Discover a novel laparoscopic approach for iatrogenic diaphragmatic hernia repair following pedicled omentoplasty. This modified Sugarbaker technique integrates dorsal pedicle lateralization and round ligament reinforcement to secure the diaphragmatic defect while preserving vital omental vascularity.
Today

A cervical giant cell tumour presents rare diagnostic hurdles in spinal oncology. Image-guided FNAC provides rapid, reliable evaluation by identifying bland mononuclear stromal cells intimately admixed with osteoclast-type giant cells, aiding timely surgical planning and organ-preserving targeted management.
Today

New research reveals that M1 macrophage-derived exosomes aggravate diabetic nephropathy by transferring WTAP to stabilize S1PR2 mRNA. Silencing WTAP in these vesicles attenuates endothelial injury and renal fibrosis, pointing toward innovative nanomedicine therapies.
Today